Alcon Secures FDA Approval for BRYTLY, Outlasting Leading Competitor by 50%

Alcon received U.S. Food and Drug Administration approval for BRYTLY, an over-the-counter (OTC) redness reliever eye drop. The product provides relief in as little as one minute.

Each application offers up to 12 hours of redness relief. Alcon stated the product lasts 50% longer than Bausch + Lomb's Lumify, its primary competitor.

The approval expands Alcon's consumer health portfolio. BRYTLY is expected to be available at major U.S. retailers and online in the coming months.